Larkspur Biosciences
is a Massachusetts-based biotechnology company that researches and develops precision immunotherapies for the treatment of cancer... Read moreLarkspur Biosciences
is a Massachusetts-based biotechnology company that researches and develops precision immunotherapies for the treatment of cancer... Read more
2020
PrivateIndependent Company
News
Mar 28, 2024
StreetInsider
Larkspur Biosciences: Larkspur Biosciences to Present New Preclinical Research on Lead Development Program Candidate, a First-in-Class PIP4K2C Protein Degrader, at AACR 2024
Oct 25, 2023
GlobeNewswire
Press Release: Larkspur Biosciences : Larkspur Biosciences to Present New Mechanistic Data on the Role of Pin1 in Modulating the Fibroblast - Cancer Axis at SITC 2023
Jun 26, 2023
GlobalNewswire
Press Release: Larkspur Biosciences : Larkspur Biosciences Announces First-in-Class Program Targeting Novel B Cell Checkpoint
May 30, 2023
Startup Around
Larkspur Biosciences: Larkspur Biosciences Raises $35.5M in Financing
May 30, 2023
GlobeNewswire
Press Release: Larkspur Biosciences : Larkspur Biosciences to Participate in the 2023 BIO International Convention
May 24, 2023
FinSMEs
Larkspur Biosciences: Larkspur Biosciences Raises $35.5M in Financing
May 23, 2023
Endpoints News
Larkspur Biosciences: Larkspur Biosciences kicks off with $30M+, hunting for new oncology immunotherapies
